Dr. Peter Hubert Cygan, MD

Dr. Cygan practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Cygan's NPI, 1538488697, was assigned on May 27, 2010. Dr. Cygan graduated from Jagiellonian University Medical College in 2010. Dr. Cygan holds Pennsylvania license MD450123.

Dr. Cygan's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Dr. Cygan's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Cygan to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cygan practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Cygan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Cygan is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Cygan's licenses on file in 2 states: Pennsylvania and Illinois.

Dmand AI lists chronic anemia, chronic embolism thrombosis and deep vein thrombosis (DVT) among the conditions Dr. Cygan treats.

CMS data shows 69 Medicare services from Dr. Cygan across 3 procedure codes in 2024, for 82 Medicare patients. Medicare paid $4,473 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Cygan in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cygan's median patient age at 54, with 56% women.

In 2024, Dr. Cygan wrote 273 Medicare Part D claims for 57 patients. 65% of them were for generic drugs. CMS names the drug for 200 of them, across 9 drugs with 11 or more claims each, at $297,956 in total drug cost. In 2023, CMS named 167 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Cygan for performance year 2024, reported as part of a group. Dr. Cygan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cygan as offering telehealth.

Dmand AI links 11 papers to Dr. Cygan, published from 2013 to 2024. 2013 was the busiest year, with 3. The most frequent topics are Factor VIII, Hemophilia A and Antineoplastic Combined Chemotherapy Protocols. Dr. Cygan's most frequent co-authors are Peter A. Kouides, MD, Chadi Nabhan, MBA, MD and Jacob D. Bitran, MD.

CMS Open Payments shows 18 general payments to Dr. Cygan from 7 drug and device companies from 2016 to 2025. Grants make up the largest share, 97% of the total. Biogen, Inc. paid the most, $75,075.

Dr. Cygan graduated from Jagiellonian University Medical College in 2010.

Dr. Cygan is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.